Common Side Effects of Neupogen
Neupogen (filgrastim), used to boost white blood cell production in cancer patients or those with neutropenia, most often causes bone pain, back pain, and fatigue. Other frequent effects include nausea, diarrhea, headache, fever, rash, cough, and sore throat. These typically occur in more than 10% of patients and are usually mild to moderate.[1][2]
Serious Side Effects and Risks
Serious reactions include acute respiratory distress syndrome (ARDS), with symptoms like fever, cough, and trouble breathing, sometimes leading to hospitalization. Splenic rupture is rare but life-threatening, signaled by left upper abdominal pain or shoulder pain. Allergic reactions (hives, swelling, anaphylaxis) and capillary leak syndrome (hypotension, edema) also occur. Long-term use raises risks of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), especially in cancer patients.[1][2][3]
Side Effects by Patient Group
In chemotherapy patients, bone pain affects up to 30%, often managed with pain relievers. Pediatric patients report similar issues, plus thrombocytopenia. Those with severe chronic neutropenia face higher infection risks despite treatment. Sickle cell patients may experience painful crises or acute chest syndrome.[2][3]
How Side Effects Compare to Neulasta
Neupogen's daily injections lead to more frequent bone pain than Neulasta (pegfilgrastim), a longer-acting version given once per cycle with peak pain around day 2-3. Both share ARDS and leukemia risks, but Neulasta has slightly higher rates of musculoskeletal pain.[1][3]
Managing and Reporting Side Effects
Bone pain responds to acetaminophen or NSAIDs; severe cases may need opioids. Monitor for spleen enlargement via ultrasound. Report serious effects to FDA's MedWatch or your doctor immediately. Most resolve after stopping treatment.[2]
[1] https://www.neupogen.com/
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/103353s5195lbl.pdf
[3] https://www.drugs.com/sfx/neupogen-side-effects.html